Moreover, a study showed that in vivo PD-1− tumor-associated macrophages removed anti-PD-1 mAbs from the surface of PD-1+CD8+ T cells, mediated by the interaction between FcγII/III receptors and the anti-PD-1 Fc domain glycan (353). Here, CD8A is linked to neoplasm.